Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Pfizer’s Lipitor Plan Might Not Be ‘Worth It,’ Watson CEO Says
Pfizer’s Lipitor Plan Might Not Be ‘Worth It,’ Watson CEO Says
Pfizer’s Lipitor Plan Might Not Be ‘Worth It,’ Watson CEO Says
Submitted by
admin
on January 25, 2012 - 10:34am
Source:
Bloomberg
News Tags:
Pfizer
Lipitor
generics
Pharma CEOs
Watson
Paul Bisaro
Headline:
Pfizer’s Lipitor Plan Might Not Be ‘Worth It,’ Watson CEO Says
Do Not Allow Advertisers to Use My Personal information
